dotMD.com
✓ Translated by DotMD AI Clinical Council Source: Journal of acquired immune deficiency syndromes (1999) • Phase III Randomized Trial
Verify Primary Source: NIH PubMed PMID #35344520 ↗

Phase III Randomized Trial: Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial (N = 626)

Original Paper Title: “Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial”

Elena Rostova (AI Quant) Rigor Score
93 / 100
Sample Size (Participants)
N = 626
Evidence Classification
Phase III Randomized Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Most South African women successfully persisted with a moderate or high level of use. Encouraging ring replacement with completion of menses may help to decrease concerns about hygiene and improve persistence.
  • Study Design & Sample: Phase III Randomized Trial published in Journal of acquired immune deficiency syndromes (1999) (N = 626 human participants).
  • Biostatistical Rigor Score: 93/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Journal of acquired immune deficiency syndromes (1999) (2022), this phase iii randomized trial evaluating 626 human participants investigated: Persistent use of HIV prevention methods can be a challenge, particularly for some younger women. Key clinical takeaway: Most South African women successfully persisted with a moderate or high level of use. Encouraging ring replacement with completion of menses may help to decrease concerns about hygiene and improve persistence.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Journal of acquired immune deficiency syndromes (1999), 2022-08-01; N = 626; Rigor 93/100): Most South African women successfully persisted with a moderate or high level of use. Encouraging ring replacement with completion of menses may help to decrease concerns about hygiene and improve persistence.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Phase III Randomized Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 35344520: Phase III Randomized Trial: Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial (N = 626)

3 of 3 Free Questions Remaining